Press Releases China Grand Pha.and Healthcare Hld. Ltd. Hong Kong S.E.

Equities

0512

BMG210A71198

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

China Monthly Antitrust Update - June 2023	23-06-28	AQ
Telix-Grand Pharma Investor Webcast	23-04-21	AQ
VOLUNTARY ANNOUNCEMENT: SIR-SPHERES Y-90 RESIN MICROSPHERES DOSED THE FIRST HCC PATIENT OF THE U.S. CLINICAL TRIAL	21-05-10	PU
China Grand Pharmaceutical and Healthcare : Proxy form for the annual general meeting to be held on 1 June 2021 or any adjournment thereof	21-04-28	PU
China Grand Pharmaceutical and Healthcare : GENERAL MANDATE TO REPURCHASE SHARES AND ISSUE NEW SHARES; RE-ELECTION OF RETIRING DIRECTORS AND APPOINTMENT OF DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING	21-04-28	PU
OncoSec Medical Incorporated : GP (HK)'s Global Innovation Product STC3141 Receives Approval for a Phase IIa Clinical Trial of COVID-19 in Belgium ?OncoSec's Gene Electrotransfer Device GenPulse Receives the CE Mark Certification from EU	21-04-21	AQ
VOLUNTARY ANNOUNCEMENT: THE GLOBAL INNOVATION PRODUCT OF THE GROUP STC3141 WAS APPROVED TO COMMENCE PHASE IIa CLINICAL RESEARCH IN RELATED TO COVID-19 IN BELGIUM	21-04-19	PU
VOLUNTARY ANNOUNCEMENT: ONCOSEC RECEIVED THE CE MARK CERTIFICATION FROM EU FOR ITS GENE ELECTROTRANSFER DEVICE GENPULSE	21-04-19	PU
China Grand Pharmaceutical and Healthcare : GP (HK) Announces 2020 Annual Results	21-03-19	AQ
China Grand Pharmaceutical and Healthcare Holdings Limited : - SIR-Spheres Y-90 Resin Microspheres Obtains Recommendation from NICE and Approval from the FDA to Conduct Clinical Trials on Primary Liver Cancer	21-03-10	AQ
VOLUNTARY ANNOUNCEMENT: SIR-SPHERES Y-90 RESIN MICROSPHERES OBTAINED RECOMMENDATION FROM NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE); AND SIRTEX OBTAINED AN APPROVAL FROM FDA TO CONDUCT CLINICAL TRIALS ON PRIMARY LIVER CANCER	21-03-08	PU
China Grand Pharmaceutical and Healthcare : GP (HK)'s Independently Developed Innovative Glaucoma Treatment Drug Obtained Drug Registration Certificate Breaking Through the Blue Ocean of The Ophthalmic Market Segment	21-03-04	AQ
China Grand Pharmaceutical and Healthcare : GP (HK)'s First-In-Class Drug STC3141 for Sepsis has been granted A 'Notice of Approval for Clinical Trial of Drugs' issued by the NMPA	21-03-04	AQ
VOLUNTARY ANNOUNCEMENT: FIRST PATIENT DOSED IN THE PHASE 1B CLINICAL TRIAL FOR SEPSIS OF THE GROUP FIRST-IN-CLASS DRUG STC3141	21-03-03	PU
VOLUNTARY ANNOUNCEMENT: DRUG REGISTRATION CERTIFICATE FOR BIMATOPROST EYE DROPS WAS ISSUED	21-03-03	PU
China Grand Pharmaceutical and Healthcare : GP (HK) Announces Positive Profit Alert the Expected Increase in Consolidated Net Profit Attributable to Owners of the Company for FY2020 No Less Than 40%	21-02-22	AQ
China Grand Pharmaceutical and Healthcare : GP (HK) and eTheRNA Enters into Exclusive Strategic Cooperation and Licensing Agreement on World-class Innovative Products in Greater China	20-11-30	AQ
Telix Pharmaceuticals Limited : and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market	20-11-02	AQ
China Grand Pharmaceutical and Healthcare : Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market	20-11-01	AQ
China Grand Pharmaceutical and Healthcare : INTERIM REPORT 2020	20-09-17	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases China Grand Pha.and Healthcare Hld. Ltd. Hong Kong S.E.

Equities

0512

BMG210A71198

Press Releases

Filters